l carnitine congestive heart failure is a friend in HFpEF and foe in HFrEF L-carnitine and heart disease –
Description
BRCA1/2 mutations and bevacizumab in the neoadjuvant treatment of breast cancer: response and prognosis results in patients with triple-negative breast cancer from the GeparQuinto study
The prevalence of chronic fatigue and CFS in Gulf war participants was 5.1% and 2.2%, respectively (Son 2012)
In contrast, the association between Lp(a) and the risk of venous thromboembolism is not supported by most recent studies [7, 8]
Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria
